A world first study shows CRISPR can remove a target gene from early stage human embryos. But with the advance in science come weighty ethical dilemmas.
A team in the U.S. is said to have safely and effectively altered human embryos. The news is a reminder that citizens must be consulted on developments potentially affecting the future of the species.
The news may have come as a surprise, but it probably shouldn't have. A bioethics expert walks through how big a deal this announcement is – and what we should be considering now.
A new evolutionary perspective on what's been a medical paradox: Why does the body use inflammation to regulate aspects of pregnancy when inflammation is also a big threat to pregnancy?
Stem-cell scientists have to work within many limitations placed on their research. One of these is the 14-day rule that outlaws research on pure human embryos over two weeks old.
While gene editing offers the exciting potential for disease therapies, using it on human embryos opens up a can of worms.